Oral polysaccharide-iron complex was effective and safe over 24 weeks for maintaining iron in patients receiving maintenance hemodialysis. Oral iron polysaccharide complex is noninferior to ...

Do most newly diagnosed advanced NSCLC patients need nutritional intervention? This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This abstract does not include a full text component.

Approval Granted with Competitive Generic Therapy Eligibility for 100mg/5mL and 200mg/10mL Strengths; Provides Eligibility for 180 Days of Exclusivity Viatris Chief R&D Officer Philippe Martin said, ...

According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to Venofer® for the treatment of iron deficiency anemia in patients with ...